首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1425170

寵物補充品硫酸軟骨素市場：預測（2024-2029）

Chondroitin Sulfate for Pet Supplements Market - Forecasts from 2024 to 2029

出版日期: 2024年01月31日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

2022年寵物補充品市場硫酸軟骨素市值為726,786,000美元。

硫酸軟骨素是一種天然存在於軟骨（關節骨周圍的保護組織）中的化合物，廣泛用於寵物補充品中，以促進關節健康，尤其是對抗骨關節炎(OA) 的狗和貓。它的成分含有飼主在處理寵物的骨關節疾病時通常依賴日常關節補充品。這些補充品被稱為軟骨保護劑，也可用於減少身體各部位的發炎，特別是那些接觸體液和黏液的部位。例如，由於膀胱內壁發炎而頻繁排尿的寵物可能會受益於含有葡萄糖胺和軟骨素的製劑。

葡萄糖胺和軟骨素等軟骨保護劑受到許多飼主的青睞，因為它們具有整體性，可以促進寵物的整體健康，而不是簡單地緩解症狀。此外，這些補充品的副作用往往較少，使您的寵物減少對處方藥的依賴。重要的是，軟骨保護補充品通常被認為長期使用是安全的，並且可以陪伴寵物的一生。雖然服用軟骨素補充品以應對關節損傷是可取的，但也建議在寵物生命早期開始服用關節補充品作為預防措施。

市場促進因素

寵物擁有量增加

在全球範圍內，將寵物融入生活方式改變的趨勢日益明顯，使它們成為世界各地必不可少的伴侶。 COVID-19 大流行導致寵物擁有量增加，特別是在美國，2016 年至 2020 年間，擁有至少一隻狗的家庭比例從 38% 增加到 45%，養貓的比例也從2022 年從25% 增至29%。中國有 7,400 萬個家庭、美國有 8,500 萬個家庭、歐盟有 9,200 萬個家庭擁有一隻狗。這些數字凸顯了寵物世界的重要性及其對硫酸軟骨素市場的影響。

人們越來越認知到硫酸軟骨素的重要性

由於人們越來越認知到硫酸軟骨素在促進狗和貓的關節健康方面的潛在益處，因此它在寵物補充品領域越來越受歡迎。由於擔心可能的副作用，寵物飼主擴大尋求自然的方式來照顧他們的寵物。來自軟骨和貝類等天然來源的硫酸軟骨素符合這種偏好，並且可能是更安全的選擇。寵物看護者越來越意識到骨關節炎 (OA) 對寵物生活品質的負面影響。

市場挑戰

監理挑戰構成障礙

監管挑戰是寵物補充品領域的一個障礙。目前，AAFCO 僅監督為「食品類型」的補充品的標籤。儘管有關寵物補充品和食品營養補充的科學資訊不斷增加，但市場上大多數這些物質及其相應產品的品管、安全性和有效性仍然有限。目前，缺乏關於寵物補充劑和動物營養品的資料。性別。儘管存在證據差距，動物補充品和營養補充的使用仍在增加。獸醫和飼主都必須提倡對這些產品進行更嚴格的監管，並呼籲製造商與研究人員更密切地合作，這不僅是為了市場，也是為了我們寵物的利益。

依寵物類型，寵物補充品的硫酸軟骨素市場分為狗和貓。

寵物補充品的硫酸軟骨素市場分為兩大類：狗和貓。在美國，6510萬個家庭將狗視為家庭不可分割的一部分。根據美國寵物產品協會 (APPA) 的數據，貓的陪伴也很重要，因為有 4,650 萬家家庭養貓。 APPA 指出，美國寵物飼主中有很大一部分是千禧世代，這凸顯了寵物在這群人生活中日益重要的重要性。

歐洲預計將在寵物補充品中佔據硫酸軟骨素的顯著佔有率

由於寵物擁有率較高，預計歐洲將在寵物補充品中佔據相當大的硫酸軟骨素佔有率。根據 FEDIAF Facts & Datas 報導，歐洲養寵物的盛行表明，歐盟有 9,000 萬個家庭接受寵物，佔家庭總數的 46%。從這些寵物的細分來看，大約有1.1億隻貓，大約9000萬隻狗，大約5000萬隻鳥類，大約3000萬隻小型哺乳動物，大約1500萬隻狗，大約1000個玻璃容器。百萬件，展示了寵物的多樣性為歐洲家庭的豐富多彩做出了貢獻。

公司產品

硫酸軟骨素 - Unibridge 的硫酸軟骨素在多種應用中發揮重要作用，包括作為補充品添加到寵物食品中。硫酸軟骨素是專為寵物配製的，通常用於緩解與骨關節炎相關的不適。它還有助於促進健康的膀胱功能。
硫酸軟骨素 - 山東海宇生物有限公司生產硫酸軟骨素（CS），一種源自動物組織的酸性黏多醣。硫酸軟骨素為白色或類白色粉末，無臭，有吸濕性。主要醫療用途是治療關節疾病、緩解疼痛、支持軟骨再生、從根本解決關節問題。
CSbioactive(R) - CSbioactive(R) 是 Bioiberica 經科學檢驗的硫酸軟骨素，已知可促進關節健康。由於科學研究的積累，CSbioactive(R)已被全球認可並採用為基準成分。該產品專為企業對企業用途而設計，作為寵物補充品的關鍵成分。

Chondroitin sulfate, a natural compound present in cartilage, the protective tissue surrounding bones in joints, is a prevalent ingredient in pet supplements aimed at promoting joint health, particularly for dogs and cats grappling with osteoarthritis (OA). Pet owners often turn to daily joint supplements when addressing bone and joint diseases in their pets. These supplements, known as chondroprotective, also find use in mitigating inflammation in various bodily areas, particularly those exposed to fluids or mucus. For instance, pets with frequent urination due to an irritated bladder lining can benefit from formulations containing glucosamine and chondroitin.

Many pet owners prefer chondroprotective like glucosamine and chondroitin due to their holistic approach, promoting overall pet well-being rather than merely alleviating symptoms. Additionally, these supplements tend to have few side effects and enable pets to rely less on prescription medications. Importantly, chondroprotective supplements are generally considered safe for long-term use, potentially for a pet's lifespan. It is advisable to administer chondroitin supplements in response to joint injuries, initiating joint supplements early in a pet's life is also recommended as a preventive measure.

Market Drivers

Rise in Pet Ownership

Worldwide, there is a growing trend of integrating pets into changing lifestyles, with pets becoming integral companions across the globe. The COVID-19 pandemic witnessed an upswing in pet adoption, notably in the United States, where the percentage of households with at least one dog increased from 38% to 45% between 2016 and 2020, and cat ownership experienced a steady rise from 25% to 29% in 2022. In China, 74 million households own dogs, the United States has 85 million dog owners, and the European Union boasts 92 million dog owners. These figures underscore the global significance of pets and their impact on the chondroitin sulfate market.

Growing awareness of the significance of chondroitin sulfate

Chondroitin sulfate is gaining popularity in the pet supplement sector as awareness grows regarding its potential advantages for enhancing joint health in dogs and cats. Faced with concerns about possible side effects, pet owners are increasingly inclined toward natural methods to address their pet's well-being. Chondroitin sulfate, sourced from natural origins such as cartilage and shellfish, aligns with this preference, presenting a potentially safer alternative. Pet caregivers are becoming increasingly cognizant of the adverse impact of osteoarthritis (OA) on their pets' quality of life.

Market Challenges

Regulatory challenges posing a hurdle

Navigating regulatory challenges poses an obstacle in the realm of pet supplements. At present, AAFCO exclusively oversees the labelling of supplements categorized as "food-type". Despite a growing body of scientific information on veterinary pet supplements and nutraceuticals, there persists a scarcity of quality control, safety, and efficacy data for the majority of these marketed substances and the corresponding products available for purchase. Despite this evidence gap, the utilization of veterinary supplements and nutraceuticals is on the rise. It is imperative for veterinarians and pet owners alike to advocate for enhanced enforcement of regulations governing these products and to call for manufacturers to collaborate more closely with researchers for the betterment of pets as well as the market.

By pet type, chondroitin sulfate for the pet supplements market is divided into dogs and cats

The chondroitin sulfate for the pet supplement market is segmented into two categories, i.e, dogs and cats- In the United States, 65.1 million households consider dogs integral family members. The feline companionship is also cherished, as revealed by the 46.5 million households that own a cat, according to the American Pet Products Association (APPA). Notably, the APPA highlights that a significant portion of pet owners in the U.S. are millennials, underscoring the growing importance of pets in the lives of this demographic.

Europe is anticipated to hold a notable share of the chondroitin sulfate for pet supplements

Europe is projected to account for a notable share of the chondroitin sulfate for pet supplements owing to the people's huge ownership of pets in these regions. As the FEDIAF Facts & Figures states the expanding landscape of pet ownership in Europe, indicates that 90 million households in the European Union have embraced the companionship of a pet, representing 46% of households. The breakdown of this pet population reveals approximately 110 million cats, 90 million dogs, 50 million birds, 30 million small mammals, 15 million aquariums, and 10 million terrariums, showcasing the diverse array of pets that contribute to the rich tapestry of European households.

Company Products

Chondroitin sulfate - Unibridge's Chondroitin sulfate plays a vital role in diverse applications, including its use in pet food as a supplement. Specifically formulated for pets, Chondroitin sulfate is commonly employed to alleviate discomfort associated with osteoarthritis. Additionally, it contributes to the promotion of healthy bladder functions. Packaged in convenient 25kg drums, this product is well-suited for various needs.
Chondroitin Sulfate - Shandong Haiyu Biological Co., Ltd. manufactures Chondroitin Sulfate (CS), an acid mucopolysaccharide sourced from animal tissues. Presented as a white or white-like powder without any discernible odor, it displays moisture-absorbing characteristics. Its primary medical application lies in the treatment of joint diseases, offering pain relief and supporting cartilage regeneration to address joint problems at a fundamental level. This versatile product finds various applications, including its incorporation into pet food as a supplementary additive, catering to the specific needs of pet dogs.
CSbioactive® - CSbioactive® represents Bioiberica's scientifically validated chondroitin sulfate, well-known for its promotion of joint health. Acknowledged and employed worldwide as a benchmark component, CSbioactive® is supported by an extensive body of scientific research. This product is designed for business-to-business applications, serving as a key ingredient for pet supplements.

Market Segmentation

By Purity Level

99% Level
Others

By Pet Type

By Geography

North America
USA
Others
Europe, Middle East, And Africa
UK
Germany
France
Others
Asia Pacific
China
Japan
South Korea
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. CHONDROITIN SULFATE FOR PET SUPPLEMENTS MARKET BY PURITY LEVEL

5.1. Introduction
5.2. 99% level
5.3. Others

6. CHONDROITIN SULFATE FOR PET SUPPLEMENTS MARKET BY PET TYPE

6.1. Introduction
6.2. Dogs
6.3. Cats

7. CHONDROITIN SULFATE FOR PET SUPPLEMENTS FEED MARKET BY GEOGRAPHY

7.1. Introduction
7.2. Americas
- 7.2.1. USA
- 7.2.2. Others
7.3. Europe, Middle East and Africa
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. UK
- 7.3.4. Others
7.4. Asia Pacific
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
- 7.4.4. Others